Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Part of paid clinical trials in Indian Wells, California.
- Sponsor
- Pfizer
- Study ID
- NCT01786668
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tofacitinib 2 mg — DRUG4 blinded tablets (two 1 mg tablets of tofacitinib along with two 5 mg matching placebo tablets) will be administered orally twice a day (in the AM and PM) for 12 weeks
- Tofacitinib 5 mg — DRUG4 blinded tablets (one 5 mg tablet of tofacitinib, one 5 mg and two 1 mg matching placebo tablets) will be administered orally twice a day (in the AM and PM) for 12 weeks
- Tofacitinib 10 mg — DRUG4 blinded tablets (two 5 mg tablets of tofacitinib and two 1 mg matching placebo tablets) will be administered orally twice a day (in the AM and PM) for 12 weeks
- Placebo — DRUG4 blinded tablets (two 1 mg and two 5 mg matching placebo tablets) will be administered orally twice a day (in the AM and PM) for 12 weeks
Study Details
This is the first study of oral tofacitinib in adults with active ankylosing spondylitis. It is designed to obtain information on the efficacy and safety of 3 different doses of tofacitinib.
Key Dates
- Start date
- Apr 30, 2013
- Status verified
- May 2016
- Primary completion
- Mar 31, 2015
- Completion
- Mar 31, 2015
Study Design
- Enrollment
- 208 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Tofacitinib 2 mg
- Experimental: Tofacitinib 5 mg
- Experimental: Tofacitinib 10 mg
- Placebo Comparator: Placebo
Primary Outcome Measure
Percentage of Participants Achieving 20 Percent (%) Improvement in Assessment of SpondyloArthritis International Society (ASAS) Score (ASAS 20) at Week 12 [ Time Frame: Week 12 ]
Locations (22)
Find similar trials in Indian Wells, CA
Related Studies
- Exactech Shoulder Post Market Clinical Follow-up StudyRecruiting · Exactech · Laguna Woods, California
- IMPACT - AndHealth Autoimmune Research RegistryRecruiting · AndHealth · Columbus, Ohio
- Rheumatology Diet StudyRecruiting · University of Central Florida · Orlando, Florida
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune DiseaseRecruiting · TScan Therapeutics, Inc. · Orange, California